GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (NYSE:LLY) » Definitions » Shiller PE Ratio

Eli Lilly and Co (Eli Lilly and Co) Shiller PE Ratio

: 147.71 (As of Today)
View and export this data going back to 1970. Start your Free Trial

As of today (2024-04-19), Eli Lilly and Co's current share price is $745.95. Eli Lilly and Co's E10 for the quarter that ended in Dec. 2023 was $5.05. Eli Lilly and Co's Shiller PE Ratio for today is 147.71.

The historical rank and industry rank for Eli Lilly and Co's Shiller PE Ratio or its related term are showing as below:

LLY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.02   Med: 31.17   Max: 155.29
Current: 147.71

During the past years, Eli Lilly and Co's highest Shiller PE Ratio was 155.29. The lowest was 16.02. And the median was 31.17.

LLY's Shiller PE Ratio is ranked worse than
95.53% of 515 companies
in the Drug Manufacturers industry
Industry Median: 24.57 vs LLY: 147.71

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Dec. 2023 was $2.306. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $5.05 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eli Lilly and Co Shiller PE Ratio Historical Data

The historical data trend for Eli Lilly and Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.70 42.58 63.05 74.95 115.37

Eli Lilly and Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.95 69.68 93.19 109.07 115.37

Competitive Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co Shiller PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.



Eli Lilly and Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=745.95/5.05
=147.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.306/129.4194*129.4194
=2.306

Current CPI (Dec. 2023) = 129.4194.

Eli Lilly and Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.680 99.695 0.883
201406 0.680 100.560 0.875
201409 0.470 100.428 0.606
201412 0.386 99.070 0.504
201503 0.500 99.621 0.650
201506 0.560 100.684 0.720
201509 0.750 100.392 0.967
201512 0.433 99.792 0.562
201603 0.410 100.470 0.528
201606 0.710 101.688 0.904
201609 0.730 101.861 0.928
201612 0.701 101.863 0.891
201703 -0.100 102.862 -0.126
201706 0.950 103.349 1.190
201709 0.530 104.136 0.659
201712 -1.580 104.011 -1.966
201803 1.160 105.290 1.426
201806 -0.250 106.317 -0.304
201809 1.120 106.507 1.361
201812 1.064 105.998 1.299
201903 4.310 107.251 5.201
201906 1.440 108.070 1.724
201909 1.370 108.329 1.637
201912 1.562 108.420 1.865
202003 1.600 108.902 1.901
202006 1.550 108.767 1.844
202009 1.330 109.815 1.567
202012 2.213 109.897 2.606
202103 1.490 111.754 1.726
202106 1.530 114.631 1.727
202109 1.220 115.734 1.364
202112 1.810 117.630 1.991
202203 2.100 121.301 2.241
202206 1.050 125.017 1.087
202209 1.610 125.227 1.664
202212 2.039 125.222 2.107
202303 1.490 127.348 1.514
202306 1.950 128.729 1.960
202309 -0.060 129.860 -0.060
202312 2.306 129.419 2.306

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eli Lilly and Co  (NYSE:LLY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Eli Lilly and Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co (Eli Lilly and Co) Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Executives
Lilly Endowment Inc 10 percent owner 2801 NORTH MERIDIAN ST, INDIANAPOLIS IN 46208
Donald A Zakrowski officer: Chief Accounting Officer LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Alonzo Weems officer: SVP, ERM & CECO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Patrik Jonsson officer: SVP and Pres., Lilly Bio-Meds LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Anne E. White officer: SVP & Pres-Lilly Oncology LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Eric Dozier officer: EVP, HR & Diversity LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jackson P Tai director
Mary Lynne Hedley director C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Marschall S Runge director LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Naarden Jacob Van officer: SVP, CEO LoxoONC, Pres LlyONC C/O ELI LILLY & CO, LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Diogo Rau officer: SVP & CIDO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Edgardo Hernandez officer: SVP & Pres., Mfg. Operations LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Kimberly H Johnson director C/O FANNIE MAE, 1100 15TH STREET, NW, WASHINGTON DC 20005
Anat Ashkenazi officer: SVP & CFO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Gabrielle Sulzberger director 450 LEXINGTON AVENUE, FLOOR 13, NEW YORK NY 10017

Eli Lilly and Co (Eli Lilly and Co) Headlines